DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HYDROCORTISONE; UREA
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
HYDROCORTISONE; UREA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITIGLINIDE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
MITIGLINIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
D86I0XLB13
Molecule Type:
Small molecule
Molecular Formula:
C19H25NO3
Molecular Weight:
315.41
AlogP:
2.97
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LYCOPENE
4
Small molecule
Approved
Unknown
Unknown
Periodontitis; Prostatic Intraepithelial Neoplasia; Lichen Planus; Periodontal Pocket; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Atherosclerosis; Coronary Disease
Unknown
LYCOPENE
×
Maximum Phase:
4
First Approval:
None
UNII:
SB0N2N0WV6
Molecule Type:
Small molecule
Molecular Formula:
C40H56
Molecular Weight:
536.89
AlogP:
12.94
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
16.0
Source:
PINE TAR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PINE TAR
×
Maximum Phase:
4
First Approval:
None
UNII:
YFH4WC535J
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CELLULOSE, OXIDIZED
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CELLULOSE, OXIDIZED
×
Maximum Phase:
4
First Approval:
None
UNII:
44AIH82TSC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETRIZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACETRIZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
24256BQV7M
Molecule Type:
Small molecule
Molecular Formula:
C9H6I3NO3
Molecular Weight:
556.86
AlogP:
3.16
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
2.0
Source:
METHENAMINE MANDELATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METHENAMINE MANDELATE
×
Maximum Phase:
4
First Approval:
None
UNII:
695N30CINR
Molecule Type:
Small molecule
Molecular Formula:
C14H20N4O3
Molecular Weight:
292.34
AlogP:
-1.02
PSA:
12.96
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PERTUSSIS VACCINE
4
Unknown
Approved
Unknown
Unknown
Pneumococcal Infections; Streptococcal Infections; Meningococcal Infections; Tetanus; Whooping Cough
Unknown
PERTUSSIS VACCINE
×
Maximum Phase:
4
First Approval:
None
UNII:
2QNL82089R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRACTOLOL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Beta-1 adrenergic receptor inhibitor
PRACTOLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
SUG9176GRW
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O3
Molecular Weight:
266.34
AlogP:
1.38
PSA:
70.59
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PEGFILGRASTIM-JMDB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PEGFILGRASTIM-JMDB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PYROVALERONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PYROVALERONE
×
Maximum Phase:
4
First Approval:
None
UNII:
VOU69C02JP
Molecule Type:
Small molecule
Molecular Formula:
C16H23NO
Molecular Weight:
245.37
AlogP:
3.44
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CLOFOREX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLOFOREX
×
Maximum Phase:
4
First Approval:
None
UNII:
2QJT5ZC1L6
Molecule Type:
Small molecule
Molecular Formula:
C13H18ClNO2
Molecular Weight:
255.75
AlogP:
3.41
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FOMIVIRSEN
4
Oligonucleotide
Approved
Unknown
Unknown
Eye Infections
Major intermediate early region 2 mRNA antisense inhibitor
FOMIVIRSEN
×
Maximum Phase:
4
First Approval:
None
UNII:
QX5LK7YCHV
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIOTRIX (T4;T3)
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LIOTRIX (T4;T3)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMELAINS
4
Unknown
Approved
Unknown
Unknown
Neoplasms; Skin Ulcer
Unknown
BROMELAINS
×
Maximum Phase:
4
First Approval:
None
UNII:
U182GP2CF3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
4
Combination
Approved
Unknown
NASAL
Unknown
Unknown
OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIAMMINE SILVER FLUORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIAMMINE SILVER FLUORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLURBIPROFEN AXETIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FLURBIPROFEN AXETIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM RANELATE
4
Small molecule
Approved
Unknown
Unknown
Bone Diseases
Unknown
STRONTIUM RANELATE
×
Maximum Phase:
4
First Approval:
None
UNII:
04NQ160FRU
Molecule Type:
Small molecule
Molecular Formula:
C12H6N2O8SSr2
Molecular Weight:
513.49
AlogP:
-0.08
PSA:
176.23
HBD:
4.0
HBA:
#RotB:
8.0
Source:
AGOMELATINE
4
Small molecule
Approved
Unknown
Unknown
Obsessive-Compulsive Disorder; Anxiety; Dementia; Depressive Disorder, Major; Schizophrenia; Depressive Disorder
Melatonin receptor agonist
AGOMELATINE
×
Maximum Phase:
4
First Approval:
None
UNII:
137R1N49AD
Molecule Type:
Small molecule
Molecular Formula:
C15H17NO2
Molecular Weight:
243.31
AlogP:
2.53
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAZANAVIR SULFATE; COBICISTAT
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ATAZANAVIR SULFATE; COBICISTAT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TANDOSPIRONE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TANDOSPIRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EVENING PRIMROSE OIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EVENING PRIMROSE OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RANELIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
RANELIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
K9CCS0RIBT
Molecule Type:
Small molecule
Molecular Formula:
C12H10N2O8S
Molecular Weight:
342.29
AlogP:
-0.08
PSA:
176.23
HBD:
4.0
HBA:
#RotB:
8.0
Source:
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MINERAL OIL
4
Small molecule
Unknown
Unknown
Unknown
Skin Diseases; Constipation; Diaper Rash
Unknown
MINERAL OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
T5L8T28FGP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM TANSHINONE IIA SULFONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM TANSHINONE IIA SULFONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMEPRONIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EMEPRONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
WZM699L2TL
Molecule Type:
Small molecule
Molecular Formula:
C20H28BrN
Molecular Weight:
362.36
AlogP:
4.69
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DARUNAVIR HYDRATE
4
Unknown
Approved
Unknown
ORAL
Unknown
Unknown
DARUNAVIR HYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
272
273
274
275
276
277
278
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA